I’m talking with serial entrepreneurBill Malkes, founder ofNellOne Therapeutics, an early stage biopharmaceutical company advancing the development of novel regenerative medicine therapies based on the functional activities of the NELL1 protein. We talk about the amazing role in healing played by NELL1, the successful sale of GRIDSMART, the imperative of failing fast, and why now is a great time for entrepreneurship in East Tennessee. Bill is readingIt Can’t Happen Here by Sinclair Lewis, listening to Revisionist History, A Second Opinion, and Solvable, and followingPaul Krugman, Andrea Mitchell, Dr. Emily Porter, and Susan Rice.
